DE69227773T2 - Tabletten mit hohem gehalt an colestipolhydrochlorid - Google Patents

Tabletten mit hohem gehalt an colestipolhydrochlorid

Info

Publication number
DE69227773T2
DE69227773T2 DE69227773T DE69227773T DE69227773T2 DE 69227773 T2 DE69227773 T2 DE 69227773T2 DE 69227773 T DE69227773 T DE 69227773T DE 69227773 T DE69227773 T DE 69227773T DE 69227773 T2 DE69227773 T2 DE 69227773T2
Authority
DE
Germany
Prior art keywords
tablet
scus
mins
excipients
inch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69227773T
Other languages
English (en)
Other versions
DE69227773D1 (de
Inventor
Robert Shen
Jeffrey Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE69227773D1 publication Critical patent/DE69227773D1/de
Application granted granted Critical
Publication of DE69227773T2 publication Critical patent/DE69227773T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
DE69227773T 1991-07-03 1992-06-23 Tabletten mit hohem gehalt an colestipolhydrochlorid Expired - Lifetime DE69227773T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (2)

Publication Number Publication Date
DE69227773D1 DE69227773D1 (de) 1999-01-14
DE69227773T2 true DE69227773T2 (de) 1999-05-20

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227773T Expired - Lifetime DE69227773T2 (de) 1991-07-03 1992-06-23 Tabletten mit hohem gehalt an colestipolhydrochlorid

Country Status (18)

Country Link
US (1) US5490987A (de)
EP (1) EP0592594B1 (de)
JP (1) JP3313710B2 (de)
KR (1) KR100240362B1 (de)
AT (1) ATE173931T1 (de)
AU (1) AU669664B2 (de)
CA (1) CA2110166C (de)
CZ (1) CZ286958B6 (de)
DE (1) DE69227773T2 (de)
DK (1) DK0592594T3 (de)
ES (1) ES2124736T3 (de)
FI (1) FI106843B (de)
HU (1) HU222242B1 (de)
NO (1) NO307686B1 (de)
PL (1) PL169045B1 (de)
RU (1) RU2108090C1 (de)
SK (1) SK281920B6 (de)
WO (1) WO1993000915A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
AU778262B2 (en) * 1999-10-19 2004-11-25 Genzyme Corporation Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
WO2005065291A2 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1951266A2 (de) 2005-09-02 2008-08-06 Genzyme Corporation Verfahren zur entfernung von phosphat und dafür verwendetes polymer
PT1924246E (pt) 2005-09-15 2016-02-10 Genzyme Corp Formulação sachê para polímeros com funcionalidade amina
KR20090051240A (ko) * 2006-09-01 2009-05-21 유에스브이 리미티드 세벨라머 염산염의 제조방법 및 그의 제형
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
RU2011112694A (ru) * 2008-09-02 2012-10-10 Юсв Лимитед (In) Сшитые полимеры
WO2010086881A2 (en) * 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
ATE91627T1 (de) * 1988-06-24 1993-08-15 Upjohn Co Feingemahlenes colestipol-hydrochlorid.
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
KR900701285A (ko) * 1988-08-26 1990-12-01 로버어트 에이 아미테이지 미세-구슬상 콜레스티폴 염산염

Also Published As

Publication number Publication date
HUT69394A (en) 1995-09-28
DE69227773D1 (de) 1999-01-14
FI935943A (fi) 1993-12-30
ATE173931T1 (de) 1998-12-15
FI935943A0 (fi) 1993-12-30
HU9400004D0 (en) 1994-05-30
NO307686B1 (no) 2000-05-15
NO940008L (no) 1994-01-03
SK281920B6 (sk) 2001-09-11
RU2108090C1 (ru) 1998-04-10
KR100240362B1 (ko) 2000-02-01
HU222242B1 (hu) 2003-05-28
EP0592594B1 (de) 1998-12-02
EP0592594A1 (de) 1994-04-20
CA2110166A1 (en) 1993-01-21
JP3313710B2 (ja) 2002-08-12
ES2124736T3 (es) 1999-02-16
SK194A3 (en) 1994-11-09
WO1993000915A1 (en) 1993-01-21
CZ282693A3 (en) 1994-06-15
US5490987A (en) 1996-02-13
CZ286958B6 (cs) 2000-08-16
FI106843B (fi) 2001-04-30
AU669664B2 (en) 1996-06-20
AU2293392A (en) 1993-02-11
PL169045B1 (pl) 1996-05-31
NO940008D0 (no) 1994-01-03
CA2110166C (en) 2002-11-05
JPH06509097A (ja) 1994-10-13
DK0592594T3 (da) 1999-08-16

Similar Documents

Publication Publication Date Title
ATE173931T1 (de) Tabletten mit hohem gehalt an colestipolhydrochlorid
US4990535A (en) Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
MX9500243A (es) Composicion de liberacion acelerada que contiene bromocriptina.
ATE97571T1 (de) Tablette mit doppelwirkung.
AU2725392A (en) Hiv protease inhibitors
NO942325L (no) Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
NO308644B1 (no) Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
Chapman Postoperative pain control for outpatient oral surgery
ATE258788T1 (de) Tablette
Lim et al. The antiemetic and sysphoric effects of droperidol in the day surgery patient
BG101803A (en) Use of melatonin for treating patients suffering from drug addiction
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
Ockelford et al. A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (Fragmin) in patients having major elective general surgery
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
Gumpel Cyclophosphamide, gold and penicillamine—disease-modifying drugs in rheumatoid arthritis—tailored dosage and ultimate success
Taylor et al. Laparoscopic vagotomy: an operation for the 1990s?
Segal et al. A polyamine formaldehyde resin IV. Clinical evaluation in the treatment of duodenal ulcer
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
GB2174004A (en) Effervescent tablets
CA2184361C (en) Solid dose forms containing bismuth
EP0681476B1 (de) Wismutsubsalicylat in form einer einheitsdosis
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 592594

Country of ref document: EP